Dr. Reddys Laboratories Ltd.
BSE: 500124 | NSE: DRREDDY
Mid Cap | Pharmaceuticals & Drugs
1244.05
9.45
(0.77%)
< Home
< Back
Dr. Reddys Laboratories Ltd. News
>>
Dr. Reddy's Laboratories reports 18% rise in Q1 consolidated net profit
>>
Dr. Reddy's Lab - Quaterly Results
>>
Dr. Reddy's Lab reports Profit after tax of Rs 16394.00 Mln, in the June 2023 quarter
>>
Dr. Reddy's Lab - Quaterly Results
>>
Dr. Reddy's Lab - Quaterly Results
>>
USFDA completes PAI, GMP inspection at Dr. Reddy's Laboratories’ Andhra Pradesh facility
>>
Genus Power Infrastructures, Olectra Greentech and DLF to see some action today
>>
Dr. Reddy's Laboratories to invest in O2 Renewable Energy IX
>>
Dr. Reddy’s proposed rituximab biosimilar application accepted for review by USFDA
>>
Dr Reddy's Laboratories trades higher on eyeing to enhance presence in emerging segments like nutraceuticals
<<
<
21
22
23
...143
>
>>